Document Detail

Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as "Glia Depressing Factor" (GDF).
MedLine Citation:
PMID:  22084585     Owner:  NLM     Status:  PubMed-not-MEDLINE    
The endogenous neuroinhibitory amino acid receptor antagonist kynurenic acid (KYNA) has been hypothetically linked to physiological processes and to the pathogenesis of several brain disorders. The aim of this study was to search KYNA metabolism i.e. KYNA levels and enzymes synthesising KYNA kynurenine aminotransferase I and II (KAT I and II) in the central nervous system (CNS) and in the peripheral nervous system. Within the investigated species we found a remarkably low KYNA content (3.4 nM) in piglet's serum compared to rat and human serum. Furthermore, in contrast to high KAT activity present in rat and human livers, a lack of KAT I and KAT II activity was found in piglet liver and other piglet peripheral organs. Therefore we attempted to find a reason for the absence of KYNA formation in piglet peripheral tissue and we researched to find if KYNA formation in rat liver homogenate (measured under standard assay conditions for KAT activity) can be influenced by the application of piglet tissue homogenates and other body fluids. KYNA formation in rat liver homogenate was investigated in the presence of piglet liver, piglet brain, rat brain and human brain homogenates, and also in the presence of cerebrospinal fluid (CSF) of the control and of Multiple Sclerosis patients. We found a significant and dose dependent reduction of rat liver KAT I and KAT II activities in the presence of piglet brain, piglet liver, and human brain, but not in the presence of rat brain homogenate. Interestingly, CSF of the human control subjects significantly lowered rat liver KAT I activity. Furthermore, the inhibitory effect of CSF of Multiple Sclerosis (MS) patients was significantly weaker when compared to the CSF of control subjects. Our data, for the first time, indicated the presence of active component(s)-depressing factor-in the body, which was able to block KYNA formation. Reduced KAT inhibitory effect by CSF of MS patients would suggest a lowered "depressing factor" level in CSF of MS patients and is possibly responsible for an enhancement of KYNA formation and for glia activation and gliosis in the CNS. Subsequently, two fractions obtained after centrifugation of CSF from patients with Neuroborreliosis showed a significantly different ability to block KAT I activity. The CSF-sediment fraction exerts a stronger inhibitory activity than the CSF-supernatant fraction, supporting further the presence of a depressing factor. For the first time, data revealed and demonstrated the ability of endogenous components to block KYNA's synthesis. We propose that a glia depressing factor (GDF), which is abundantly present in the body, might simultaneously control glia cell's KAT activity, respectively KYNA synthesis and also glia proliferation. The mechanism(s) of action, the composition and structure of this factor needs to be further elaborated.
Halina Baran; Berthold Kepplinger; Markus Draxler
Related Documents :
22503455 - Metoprine induced behavioral modifications and brain regional histamine increase in wag...
25141045 - Cultured neonatal rat cardiomyocytes display differences in glucose uptake and sensitiv...
19089625 - The characteristics of motor activity in isiah rats in an open field test are controlle...
3579995 - Effect of relative humidity on the movement of rat vibrissae in a 60-hz electric field.
10469265 - Tissue distribution of rat macroglobulins in tumour-bearing rats.
11072135 - Differential expression of cocaine- and amphetamine-regulated transcript-immunoreactivi...
Publication Detail:
Type:  Journal Article     Date:  2010-05-11
Journal Detail:
Title:  International journal of tryptophan research : IJTR     Volume:  3     ISSN:  1178-6469     ISO Abbreviation:  Int J Tryptophan Res     Publication Date:  2010  
Date Detail:
Created Date:  2011-11-15     Completed Date:  2011-11-23     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101513378     Medline TA:  Int J Tryptophan Res     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  13-22     Citation Subset:  -    
Neurochemical Laboratory, Karl Landsteiner Research Institute for Pain Treatment and Neurorehabilitation, LKM Mauer-Amstetten.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of the NMDA-receptor in Prepulse Inhibition in the Rat.
Next Document:  On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio.